Skip to content
value.today

Pharmaxis Ltd

PXS.AX
$43 Mlast known market cap, Jan 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Pharmaxis Ltd in brief

Pharmaxis Ltd is a listed company in the Pharmaceutical industry, based in Australia. Its last known market value was $43 M (January 2022); there is no current figure. Its shares trade under the symbol PXS.AX (ASX).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Market cap history

Not enough history yet.

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Pharmaxis Ltd🇦🇺$43 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 7, 2022 (last known)
Profile updated:
Nov 4, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Pharmaxis Ltd? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Pharmaxis Ltd's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Pharmaxis Ltd? Suggest a correction